CancerLinQ receives ASCO-certified RQS status

City of Hope deploys HopeLLM: AI platform transforms clinical workflows and patient care

City of Hope has developed and deployed HopeLLM, a proprietary generative AI platform that addresses critical operational challenges in hospitals while advancing personalized cancer care.

Richard Schilsky leaves role as PI of ASCO’s TAPUR study

Richard L. Schilsky has left his role as inaugural principal investigator of the American Society of Clinical Oncology-led Targeted Agent and Profiling Utilization Registry study after a decade of leadership.

September 05, 2025

Vol.51 No.32

Clinical Roundup

Tumor-infiltrating clonal hematopoiesis findings validated by AI analysis

Tumor-infiltrating clonal hematopoiesis is prevalent across solid tumors with the highest incidence in non-small cell lung cancer and results in a higher rate of mortality, according to a study by Caris Life Sciences that independently validates recent findings on TI-CH.

July 25, 2025

Vol.51 No.29

Imaging’s ride to the bottom in clinical trials—and why it matters now

In cancer care, imaging has become a marvel of modern medicine. Advances in scanner technology, reconstruction algorithms, contrast agents, and diagnostic protocols have radically improved our ability to detect, track, and understand disease. Clinically, imaging is fast, accurate, and central to decision-making.

ACR to launch artificial intelligence economics committee

The American College of Radiology is launching a new Artificial Intelligence Economics Committee to help consolidate available resources and develop financial strategies to address development and deployment of radiologic AI tools.

July 18, 2025

Vol.51 No.28

Clinical Roundup

AI could help pathologists match cancer patients to the right treatments faster and more efficiently, study shows

Artificial intelligence could enhance how tumor samples are analyzed in the lab—significantly improving how doctors determine the best treatment for cancer patients, a study by researchers at the Icahn School of Medicine at Mount Sinai Memorial Sloan Kettering Cancer Center, and other collaborators suggests.

July 11, 2025

Vol.51 No.27

CancerLinQ receives ASCO-certified RQS status

YOU MAY BE INTERESTED IN

City of Hope deploys HopeLLM: AI platform transforms clinical workflows and patient care

Richard Schilsky leaves role as PI of ASCO’s TAPUR study

Tumor-infiltrating clonal hematopoiesis findings validated by AI analysis

Imaging’s ride to the bottom in clinical trials—and why it matters now

ACR to launch artificial intelligence economics committee

AI could help pathologists match cancer patients to the right treatments faster and more efficiently, study shows

Renew today!

Subscriber content

Never miss an issue!

Login